Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Adoptive Immunotherapy after Haploidentical Stem Cell Transplantation with T Cells Allodepleted by Photodynamic Purging

Katia Perruccio, MD, PhD, Fabiana Topini, MSc, Antonella Tosti, Tech, Alessandra Carotti, MD, Teresa Aloisi, MD, Franco Aversa, MD, Massimo F Martelli, MD, Andrea Velardi, MD

Blood (2008) 112 (11): 1157.

https://doi.org/10.1182/blood.V112.11.1157.1157

Published: 2008

Journal Articles

One-Mutation Model Can Explain Age Incidence in AML Carrying Nucleophosmin ( NPM1 ) Mutations.

Arcangelo Liso, MD, Filippo Castiglione, PhD, Antonio Cappuccio, PhD, Fabrizio Stracci, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Susanne Schnittger, MD, Torsten Haferlach, MD, Peter Valk, MD, Bob Lowenberg, MD, Massimo F. Martelli, MD, Brunangelo Falini, MD

Blood (2007) 110 (11): 4312.

https://doi.org/10.1182/blood.V110.11.4312.4312

Published: 2007

Journal Articles

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Loredana Ruggeri, MD, PhD, Emanuela Burchielli, MD, PhD, Katia Perruccio, MD, PhD, Marusca Capanni, Martin Stern, MD, PhD, Kathrin Hafen, Franco Aversa, MD, Massimo F. Martelli, MD, PhD, Luigina Romani, MD, PhD, George Hollander, MD, PhD, Andrea Velardi, MD, PhD

Blood (2006) 108 (11): 3210.

https://doi.org/10.1182/blood.V108.11.3210.3210

Published: 2006

Journal Articles

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Loredana Ruggeri, MD, PhD, Antonella Mancusi, PhD, Marusca Capanni, M.Sc(Biol), Elena Urbani, M.Sc(Biol), Alessandra Carotti, MD, Teresa Aloisi, MD, Martin Stern, MD, Katia Perruccio, MD, PhD, Emanuela Burchielli, MD, PhD, Fabiana Topini, M.Sc(Biol), Erika Bianchi, M.Sc(Biol), Franco Aversa, MD, Massimo F. Martelli, MD, Andrea Velardi, MD

Blood (2006) 108 (11): 437.

https://doi.org/10.1182/blood.V108.11.437.437

Published: 2006

Journal Articles

Outcomes of Unrelated Cord Blood and Haploidentical Stem Cell Transplantation in Adults with Acute Leukaemia.

Vanderson Rocha, MD, PhD, Franco Aversa, MD, Myriam Labopin, MD, Guillermo Sanz, MD, Fabio Ciceri, MD, William Arcese, MD, Donald Bunjes, MD, Jacob M. Rowe, MD, Paolo Di Bartolomeo, MD, Francesco Frassoni, MD, Massimo F. Martelli, MD, Eliane Gluckman, MD

Blood (2005) 106 (11): 301.

https://doi.org/10.1182/blood.V106.11.301.301

Published: 2005

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Franco Aversa, MD, Antonio Tabilio, MD, Adelmo Terenzi, MD, Stelvio Ballanti, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Andrea Velardi, MD, Teresa Aloisi, MD, Leonardo Flenghi, MD, Jean Pierre Saab, MD, Yair M. Reisner, PhD, Massimo F. Martelli, MD

Blood (2005) 106 (11): 441.

https://doi.org/10.1182/blood.V106.11.441.441

Published: 2005

Journal Articles

Nucleophosmin Gene Mutations Are Predictors of Favourable Prognosis in Acute Myeloid Leukemia with a Normal Kayotype and Can Be Used as a New Marker for Quantitative PCR To Detect Minimal Residual Disease.

Susanne Schnittger, PhD, Claudia Schoch, MD, Wolfgang Kern, MD, Christina Mecucci, MD, PhD, Claudia Tschulik, Massimo F. Martelli, MD, Wolfgang Hiddemann, MD, Torsten Haferlach, MD, Brunangelo Falini, MD

Blood (2005) 106 (11): 223.

https://doi.org/10.1182/blood.V106.11.223.223

Published: 2005

Journal Articles

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

Antonella Mancusi, MSc, Loredana Ruggeri, MD PhD, Karina McQueen, PhD, Katia Perruccio, MD, Franco Aversa, MD, Massimo F. Martelli, MD, Peter Parham, MD PhD, Andrea Velardi, MD

Blood (2004) 104 (11): 2219.

https://doi.org/10.1182/blood.V104.11.2219.2219

Published: 2004

Journal Articles

T-Cell Depletion and No Post-Transplant Immune Suppression Provides Better Immune Recovery to Aspergillus Than Conventional T Cell-Replete Hematopoietic Transplants.

Katia Perruccio, MD, Simone Cesaro, MD, Fabiana Topini, MSc, Maria Vittoria Gazzola, MSc, Emanuela Burchielli, MD, Alessandra Barzan, MD, Franco Aversa, MD, Chiara Messina, MD, Massimo F. Martelli, MD, Andrea Velardi, MD

Blood (2004) 104 (11): 2221.

https://doi.org/10.1182/blood.V104.11.2221.2221

Published: 2004

Journal Articles

Prospects for Dendritic Cell Vaccination Against Fungal Infections in Hematopoietic Transplantation.

Katia Perruccio, MD, Silvia Bozza, MD, Claudia Montagnoli, MSc, Silvia Bellocchio, MSc, Franco Aversa, MD, Massimo F. Martelli, MD, Francesco Bistoni, MD, Andrea Velardi, MD, Luigina Romani, MD, PhD

Blood (2004) 104 (11): 2139.

https://doi.org/10.1182/blood.V104.11.2139.2139

Published: 2004

Journal Articles

Risk Factors for Outcomes of Family Haploidentical Allogeneic Stem Cell Transplantation for Adults with Acute Leukemias: A Survey on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Fabio Ciceri, MD, Myriam Labopin, MD, Vanderson Rocha, MD, Jacob M. Rowe, MD, Donald Bunjes, MD, Paolo Di Bartolomeo, MD, Francesco Frassoni, MD, Massimo F. Martelli, MD, Franco Aversa, MD

Blood (2004) 104 (11): 2146.

https://doi.org/10.1182/blood.V104.11.2146.2146

Published: 2004

NARROW

Adoptive Immunotherapy after Haploidentical Stem Cell Transplantation with T Cells Allodepleted by Photodynamic Purging

One-Mutation Model Can Explain Age Incidence in AML Carrying Nucleophosmin ( NPM1 ) Mutations.

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Outcomes of Unrelated Cord Blood and Haploidentical Stem Cell Transplantation in Adults with Acute Leukaemia.

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Nucleophosmin Gene Mutations Are Predictors of Favourable Prognosis in Acute Myeloid Leukemia with a Normal Kayotype and Can Be Used as a New Marker for Quantitative PCR To Detect Minimal Residual Disease.

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

T-Cell Depletion and No Post-Transplant Immune Suppression Provides Better Immune Recovery to Aspergillus Than Conventional T Cell-Replete Hematopoietic Transplants.

Prospects for Dendritic Cell Vaccination Against Fungal Infections in Hematopoietic Transplantation.

Risk Factors for Outcomes of Family Haploidentical Allogeneic Stem Cell Transplantation for Adults with Acute Leukemias: A Survey on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only